More articles from Minireview

You have access
Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects
Maurizio Bifulco, Claudia Grimaldi, Patrizia Gazzerro, Simona Pisanti and Antonietta Santoro

Molecular Pharmacology June 2007, 71 (6) 1445-1456; DOI: https://doi.org/10.1124/mol.106.033118
You have access
Vitamin E Analogs, a Novel Group of “Mitocans,” as Anticancer Agents: The Importance of Being Redox-Silent
Jiri Neuzil, Marco Tomasetti, Yan Zhao, Lan-Feng Dong, Marc Birringer, Xiu-Fang Wang, Pauline Low, Kun Wu, Brian A. Salvatore and Steven J. Ralph

Molecular Pharmacology May 2007, 71 (5) 1185-1199; DOI: https://doi.org/10.1124/mol.106.030122
You have access
The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State
G. Enrico Rovati, Valérie Capra and Richard R. Neubig

Molecular Pharmacology April 2007, 71 (4) 959-964; DOI: https://doi.org/10.1124/mol.106.029470
You have access
Hypoxia-Inducible Factor-1 (HIF-1)
Qingdong Ke and Max Costa

Molecular Pharmacology November 2006, 70 (5) 1469-1480; DOI: https://doi.org/10.1124/mol.106.027029
You have access
Pharmacological Targeting of Adipocytes/Fat Metabolism for Treatment of Obesity and Diabetes
Paul F. Pilch and Nils Bergenhem

Molecular Pharmacology September 2006, 70 (3) 779-785; DOI: https://doi.org/10.1124/mol.106.026104
You have access
Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review
Milin R. Acharya, Alex Sparreboom, Jürgen Venitz and William D. Figg

Molecular Pharmacology October 2005, 68 (4) 917-932; DOI: https://doi.org/10.1124/mol.105.014167
You have access
Activation of Mitogen-Activated Protein Kinases by Peroxisome Proliferator-Activated Receptor Ligands: An Example of Nongenomic Signaling
Olivia S. Gardner, Brian J. Dewar and Lee M. Graves

Molecular Pharmacology October 2005, 68 (4) 933-941; DOI: https://doi.org/10.1124/mol.105.012260
You have access
Insect GABA Receptors: Splicing, Editing, and Targeting by Antiparasitics and Insecticides
Steven David Buckingham, Philip Charles Biggin, Benedict Mark Sattelle, Laurence Andrew Brown and David Barry Sattelle

Molecular Pharmacology October 2005, 68 (4) 942-951; DOI: https://doi.org/10.1124/mol.105.015313
You have access
Molecular Pharmacology of the Interaction of Anthracyclines with Iron
X. Xu, H. L. Persson and D. R. Richardson

Molecular Pharmacology August 2005, 68 (2) 261-271; DOI: https://doi.org/10.1124/mol.105.013383
You have access
The Cardiovascular Actions of Protease-Activated Receptors
Susan F. Steinberg

Molecular Pharmacology January 2005, 67 (1) 2-11; DOI: https://doi.org/10.1124/mol.104.003103

Main menu

User menu

Search

More articles from Minireview

Pages

Navigate

More Information

ASPET's Other Journals